AU6633101A - Peptide compound and pharmaceutical compositions and medicines containing the same as the active ingredient - Google Patents

Peptide compound and pharmaceutical compositions and medicines containing the same as the active ingredient

Info

Publication number
AU6633101A
AU6633101A AU66331/01A AU6633101A AU6633101A AU 6633101 A AU6633101 A AU 6633101A AU 66331/01 A AU66331/01 A AU 66331/01A AU 6633101 A AU6633101 A AU 6633101A AU 6633101 A AU6633101 A AU 6633101A
Authority
AU
Australia
Prior art keywords
active ingredient
same
pharmaceutical compositions
peptide compound
medicines containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66331/01A
Other languages
English (en)
Inventor
Takashi Inoue
Seiji Kamiya
Akihiro Nakanishi
Norio Ohno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daicel Corp
Mitsubishi Tokyo Pharmaceuticals Inc
Original Assignee
Mitsubishi Tokyo Pharmaceuticals Inc
Daicel Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tokyo Pharmaceuticals Inc, Daicel Chemical Industries Ltd filed Critical Mitsubishi Tokyo Pharmaceuticals Inc
Publication of AU6633101A publication Critical patent/AU6633101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU66331/01A 2000-06-28 2001-06-26 Peptide compound and pharmaceutical compositions and medicines containing the same as the active ingredient Abandoned AU6633101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-195332 2000-06-28
JP2000195332A JP2003335797A (ja) 2000-06-28 2000-06-28 ペプチド化合物及びそれを有効成分とする医薬組成物
PCT/JP2001/005461 WO2002000688A1 (fr) 2000-06-28 2001-06-26 Compose peptidique, compositions pharmaceutiques et medicaments contenant ceux-ci comme principe actif

Publications (1)

Publication Number Publication Date
AU6633101A true AU6633101A (en) 2002-01-08

Family

ID=18694011

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66331/01A Abandoned AU6633101A (en) 2000-06-28 2001-06-26 Peptide compound and pharmaceutical compositions and medicines containing the same as the active ingredient

Country Status (3)

Country Link
JP (1) JP2003335797A (ja)
AU (1) AU6633101A (ja)
WO (1) WO2002000688A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006045328A (ja) * 2004-08-04 2006-02-16 Asahi Kasei Chemicals Corp ポリオレフィン製微多孔膜の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK199983A (da) * 1982-05-10 1983-11-11 Ceskoslovenska Akademie Ved Analoge til neurohypofysiske hormoner med haemmende egenskaber
NZ216417A (en) * 1985-06-18 1990-12-21 Smithkline Beckman Corp Vasopressin antagonists, preparation thereof and pharmaceutical compositions
US4687758A (en) * 1985-11-19 1987-08-18 Smithkline Beckman Corporation Des-proline-N-methylarginine vasopressins
US5373089A (en) * 1988-09-02 1994-12-13 Northwestern University Oxytocin antagonist

Also Published As

Publication number Publication date
JP2003335797A (ja) 2003-11-28
WO2002000688A1 (fr) 2002-01-03

Similar Documents

Publication Publication Date Title
AU2300699A (en) Amidino derivatives and drugs containing the same as the active ingredient
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL150224A0 (en) Lipopeptides and pharmaceutical compositions containing the same
AU2002352420A1 (en) Pyrazine compounds and pharmaceutical compositions containing them
IL150223A0 (en) Lipopeptides and pharmaceutical compositions containing the same
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
HUP0501186A2 (en) Pharmaceutical compositions comprising active vitamin d compounds
IL161940A0 (en) Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU2001233069A1 (en) Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
AU2001234114A1 (en) Drugs containing combined active ingredients
AU2001278772A1 (en) Benzoic acid derivatives and drugs containing the same as the active ingredient
HUP0102369A3 (en) Amino acid derivatives and drugs containing the same as the active ingredient
HUP0303673A3 (en) Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient
AU2001277738A1 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
HUP0303636A3 (en) Dihydronaphthalenederivative compounds and pharmaceutical compositions containing them as active ingredient
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
AU2002340573A1 (en) Powdery active ingredient formulations
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU6179600A (en) Peptides and pharmaceutical compositions comprising same
AU2001260089A1 (en) Pharmaceutical compositions comprising desglymidodrine as an active drug substance
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001274171A1 (en) Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
IL156711A0 (en) Peptide derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase